glp 1 stimulation GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes Frontiers | GLP-1 Receptor Agonists:

Diabetes mellitus is a major risk factor for both cardiovascular and chronic kidney disease (CKD) while CKD is also associated with cardiovascular morbidity

Learn about dosing issues, medical factors, lifestyle barriers, and when to explore alternative treatments with your doctor.

Start your weight-loss journey for the last time.

But for some, the drugs come with side effects they say aren't worth it.

Together, these episodes explore how GLP-1 medications work, who theyre designed for, their potential benefits and risks, what were seeing both in practice and in the broader population, what the science says, and what active people need to know

Best For: Clients who want faster, more transformative results